Objectives: Implant-related infection is a common complication after orthopedic surgery, but there is limited research focused on anaerobic infections. We retrospectively analyzed data from 80 patients with anaerobic implant-related infections in order to investigate the clinical features, bacterial distribution and antimicrobial resistant characteristics of this disease.
Methods: 80 patients who underwent implant-related infections with anaerobes were included. Pathogens were isolated and identified by matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry with verification of 16s rRNA sequencing. Antimicrobial susceptibility testing (AST) was performed using Epsilometric test (E-test).
Results: Among the 80 patients, 61.2% (49/80) were infected with anaerobes alone, while 38.8% (31/80) were co-infected with anaerobes and other bacteria. Early infection cases involving anaerobe-alone infections were significantly higher compared to the co-infection group (P < 0.001), also exhibiting lower levels of neutrophils (P = 0.033) and ESR (P = 0.046). Anaerobe-alone infections in the prosthetic joint infection group represented a higher proportion compared with other implant-related infections (P = 0.031). Among all species of anaerobes identified, the top 3 were Cutibacterium acnes, Finegoldia magna and Peptostreptococcus anaerobius. Low MIC values to vancomycin was recorded in C. acnes strains and for amoxicillin/clavulanic acid and piperacillin/tazobactam in most F. magna strains. One of the C. acnes and F. magna strains appeared multi-drug resistant except to vancomycin.
Conclusions: Anaerobe-alone infections have later first onset times and lower infection biomarker levels compared to co-infected patients. The first choice against C. acnes is vancomycin, while amoxicillin/clavulanic acid and piperacillin/tazobactam are recommended for F. magna.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.anaerobe.2021.102413 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Antibacterial Mechanisms and Clinical Impact of Sitafloxacin.
Pharmaceuticals (Basel)
November 2024
AO Research Institute Davos, 7270 Davos, Switzerland.
Article Synopsis
- Sitafloxacin is a 4th generation fluoroquinolone antibiotic effective against both Gram-negative and Gram-positive bacteria, primarily used in Japan to treat infections like pneumonia and UTIs.
- It has a low minimum inhibitory concentration (MIC) for various bacteria and is effective against anaerobes, intracellular bacteria, and biofilms, showing promise in treating implant-related infections.
- The review focuses on sitafloxacin's mechanisms, activity, resistance profile, and potential for future clinical use, suggesting further evaluation in biofilm-related infections.
In-vitro polymicrobial oral biofilm model represents clinical microbial profile and disease progression during implant-related infections.
J Appl Microbiol
November 2023
Department of Prosthodontics and Periodontology, Piracicaba Dental School, Universidade Estadual de Campinas (UNICAMP), Piracicaba, SP 13414-903, Brazil.
Aim: Clinically relevant in-vitro biofilm models are essential and valuable tools for mechanistically dissecting the etiopathogenesis of infectious diseases and test new antimicrobial therapies. Thus, the aim of this study was to develop and test a clinically relevant in-vitro oral polymicrobial biofilm model that mimics implant-related infections in terms of microbial profile.
Methods And Results: For this purpose, 24-well plate system was used to model oral biofilms, using three different microbial inoculums to grow in-vitro biofilms: (1) human saliva from periodontally healthy patients; (2) saliva as in inoculum 1 + Porphyromonas gingivalis strain; and (3) supra and subgingival biofilm collected from peri-implant sites of patients diagnosed with peri-implantitis.
Background: The use of low-temperature plasma (LTP) is a novel approach to treating peri-implantitis. LTP disrupts the biofilm while conditioning the surrounding host environment for bone growth around the infected implant. The main objective of this study was to evaluate the antimicrobial properties of LTP on newly formed (24 h), intermediate (3 days), and mature (7 days) peri-implant-related biofilms formed on titanium surfaces.
View Article and Find Full Text PDFin breast implants: an underestimated bacterial infection and review of the literature.
J Surg Case Rep
February 2023
Tweed Hospital, NSW, Australia.
Article Synopsis
- Doctors are studying how bacteria might be connected to problems some people have after getting breast implants.
- Post-surgery infections are a common reason why patients have to go back to the hospital.
- In certain cases, patients had to have their breast implants removed because of infection and other issues, but the surgeries went well and they received antibiotics afterward.
Clinical and microbiological features of anaerobic implant-related infection in 80 patients after orthopedic surgery.
Anaerobe
October 2021
Department of Clinical Laboratory, Beijing Jishuitan Hospital, Beijing, 100035, China. Electronic address:
Objectives: Implant-related infection is a common complication after orthopedic surgery, but there is limited research focused on anaerobic infections. We retrospectively analyzed data from 80 patients with anaerobic implant-related infections in order to investigate the clinical features, bacterial distribution and antimicrobial resistant characteristics of this disease.
Methods: 80 patients who underwent implant-related infections with anaerobes were included.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!